Arkolith/Insider Trading/OTLK/Form 4

Evanson Jeff

Chief Commercial OfficerOutlook Therapeutics, Inc. (OTLK) · full profile →Form 4 · filed Jan 19, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$204K
Net Open-Market Flow
-$204K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 19, 2023Sell(S)103K$1.22$126K1.0M
Jan 18, 2023Sell(S)34K$1.25$42K1.1M
Jan 17, 2023Sell(S)27K$1.31$36K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-004118) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML